These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 393641)

  • 1. Porphyria cutanea tarda.
    Muhlbauer JE; Pathak MA
    Int J Dermatol; 1979 Dec; 18(10):767-80. PubMed ID: 393641
    [No Abstract]   [Full Text] [Related]  

  • 2. Porphyria cutanea tarda simulating scleroderma.
    Goh CL
    Singapore Med J; 1987 Feb; 28(1):83-8. PubMed ID: 3603082
    [No Abstract]   [Full Text] [Related]  

  • 3. Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias.
    Grossman ME; Poh-Fitzpatrick MB
    Dermatol Clin; 1986 Apr; 4(2):297-309. PubMed ID: 3955900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Bianco L; Salvadeo A; Barosi G
    Nephrol Dial Transplant; 1992; 7(5):438-42. PubMed ID: 1321381
    [No Abstract]   [Full Text] [Related]  

  • 6. [The sclerovitiliginous form of porphyria cutanea tarda].
    Verbenko EV; Snarskaia ES; Ezhov NIa
    Vestn Dermatol Venerol; 1990; (2):75-7. PubMed ID: 2343675
    [No Abstract]   [Full Text] [Related]  

  • 7. [Porphyria cutanea tarda with scleroderma-like characteristics. Report of a case].
    Fuller R; Pastor EH; Gabriel Júnior A; dos Santos RF; Assad RL; Koperzstich S
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):47-52. PubMed ID: 4059786
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspects of primary liver cancer and its relation to porphyria cutanea tarda and porphyria acuta intermittens.
    Hardell L
    IARC Sci Publ; 1986; (77):591-2. PubMed ID: 3596757
    [No Abstract]   [Full Text] [Related]  

  • 9. Porphyria cutanea tarda associated with human immunodeficiency virus infection. A study of four cases and review of the literature.
    Boisseau AM; Couzigou P; Forestier JF; Legrain V; Aubertin J; Doutre MS; Maleville J; Geniaux M; Beylot C
    Dermatologica; 1991; 182(3):155-9. PubMed ID: 1879582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Major hypertrichosis in an adult female secondary to porphyria cutanea tarda. Its evolution with chloroquine].
    Michel B; Guillot B; Guilhou JJ; Meynadier J
    Ann Dermatol Venereol; 1983; 110(4):361-3. PubMed ID: 6625460
    [No Abstract]   [Full Text] [Related]  

  • 11. Porphyria cutanea tarda. Update 1978.
    Benedetto AV; Taylor JS
    Cutis; 1978 Apr; 21(4):483-8. PubMed ID: 416934
    [No Abstract]   [Full Text] [Related]  

  • 12. Porphyria Cutanea tarda in Missouri.
    Anderson PC
    Mo Med; 1981 Jun; 78(6):299-302. PubMed ID: 7254176
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of porphyria cutanea tarda with hemangioma of the liver.
    Iwamura K; Itakura M; Takahashi M
    Tokai J Exp Clin Med; 1983 May; 8(2):211-20. PubMed ID: 6658850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of hexachlorobenzene-induced porphyria in Turkey: clinical and laboratory follow-up after 25 years.
    Peters HA; Gocmen A; Cripps DJ; Bryan GT; Dogramaci I
    Arch Neurol; 1982 Dec; 39(12):744-9. PubMed ID: 7138315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine in the treatment of porphyria cutanea tarda.
    Tsega E; Besrat A; Damtew B; Seyoum E; Landells JW
    Trans R Soc Trop Med Hyg; 1981; 75(3):401-4. PubMed ID: 7324107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver changes in porphyria cutanea tarda patients treated with chloroquine.
    Chlumska A; Chlumsky J; Malina L
    Br J Dermatol; 1980 Mar; 102(3):261-6. PubMed ID: 7370174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis of the action of chloroquine in porphyria cutanea tarda.
    Scholnick PL; Epstein J; Marver HS
    J Invest Dermatol; 1973 Oct; 61(4):226-32. PubMed ID: 4744026
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic and pathogenetic aspects of porphyria cutanea tarda].
    Köstler E; Seebacher C; Riedel H; Kemmer C
    Hautarzt; 1986 Apr; 37(4):210-6. PubMed ID: 3009356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases.
    Sweeney GD
    Clin Biochem; 1986 Feb; 19(1):3-15. PubMed ID: 3513989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyria cutanea tarda. Remission following chloroquine administration without adverse effects.
    Saltzer EI; Redeker AG; Wilson JW
    Arch Dermatol; 1968 Nov; 98(5):496-8. PubMed ID: 5693347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.